NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

NCT07397325

RecruitingPhase 1, Phase 2

Sponsor: Applied Biology, Inc.

Conditions: Chemotherapy Induced Alopecia, Chemotherapy Side Effects

Interventions: DA-020, Placebo, DA-020 and Hyperforin

Countries: Brazil, Italy

Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia

Eligibility overview

Sex: FEMALE

Age: 18 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosed with stage I or stage II breast cancer
* Scheduled but not begun, at least 4 cycles of taxane and/or anthracycline-based chemotherapy.
* Ages 18-65
* Able to give informed consent

Exclusion Criteria:

* Resting blood pressure outside the range of 105-140/ 55-99
* Uncontrolled or severe hypertension
* Female pattern hair loss or hair loss disorder
* Folliculitis
* Scalp psoriasis
* Seborrheic dermatitis
* Inflammatory scalp conditions such as lichen planopillaris
* Subjects wearing wigs prior to chemotherapy
* Use of MAO inhibitors
* Unable to provide consent or make allotted clinical visits

Locations (2)

Manaus, Brazil
Rome, Italy